Form 4: Celanese Corp Executive Mark Christopher Murray Reports Stock Transactions
SEC Form 4 Filing
SVP of Acetyls at Celanese Corp, Mark Christopher Murray, reports acquisition and disposal of common stock related to vested performance-based restricted stock units.
Summary
- On February 15, 2025, Mark Christopher Murray, SVP Acetyls at Celanese Corp, reported transactions involving the company's common stock.
- Murray acquired 871 shares of common stock at $0 related to vested performance-based restricted stock units (PRSUs) granted on February 9, 2022.
- He also disposed of 364 shares at $69.13 for the payment of taxes on the vesting and settlement of PRSUs and previously reported time-based restricted stock units.
- Following these transactions, Murray beneficially owns 11,636 shares of Celanese Corp common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| February 9, 2022 | Date of grant for the performance-based restricted stock units (PRSUs). |
| February 15, 2025 | Date of stock acquisition and disposal. |
| February 19, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.